Recent News
RAIN Surges 120% After Biotech Firm Unveils $212M DAT Plans
Enlivex will use a private placement to accumulate the native token of decentralized prediction market protocol Rain.
Read MoreEnlivex Raises $212M for RAIN Token Prediction Market Treasury
Enlivex raises $212M in a PIPE to launch the first RAIN prediction markets token digital asset treasury, providing investors crypto exposure
Read MoreRAIN Token Explodes 100% Hourly: Did Italy’s Former PM Fuel the Surge?
The asset's market capitalization jumped above $1.7 billion.
Read MoreEnlivex names former Italy PM Matteo Renzi to board, raises $212M
Enlivex Therapeutics Ltd. (NASDAQ: ENLV) announced the appointment of former Italian Prime Minister Matteo Renzi to its board of directors, effective November 24, 2025.
Read MoreEnlivex Appoints former Italy Prime Minister Matteo Renzi to Board of Directors
Enlivex Announced today $212,000,000 private placement to initiate world's first prediction markets digital asset treasury strategy, via RAIN token accumulation
Read MoreNasdaq Biotech Firm Pivots to Crypto with $212M Investment in Prediction Market Token
Enlivex Therapeutics Invests $212 Million in Rain Token
Read MoreNasdaq penny stock plans $212M RAIN token play with ex-Italian PM onboard
A Nasdaq-listed biotech firm is raising $212 million in a late-cycle pivot into crypto, planning to buy the token of a decentralized prediction market even as other digital-asset treasuries (DATs) struggle to stay afloat.
Read MoreEnlivex Taps Matteo Renzi, Bets Big on Prediction Markets
Enlivex is betting $212 million on the RAIN prediction market token as its primary treasury asset while simultaneously appointing former Italian PM Matteo Renzi to its board.
Read MoreBiotech’s Initial Step: Blockchain Treasury Focuses on Crypto’s Most Rapidly Expanding Industry
Enlivex Therapeutics raises $212M via private placement to adopt RAIN, a blockchain-based prediction market token, marking the first U.S. public company to use such a treasury strategy.
Read More